Bulletin PRESS
NEOFLORAX
The EOF warns that the product NEOFLORAX, which is distributed via the internet sometimes as a medicine and sometimes as a dietary supplement for the treatment of parasitic infections of the human body, does not have drug approval from the EOF nor has it been notified to the EOF and therefore has not been evaluated by the EOF in terms of its safety and effectiveness.
EOF warns consumers not to purchase products under EOF's jurisdiction from unauthorized and unreliable sources on the internet.
FROM THE ADMINISTRATION
